Biosens Bioelectron. 2013;52C:255-260

Campuzano S, Salema V, Moreno-Guzmán M, Gamella M, Yáñez-Sedeño P, Fernández LA, Pingarrón JM.

Biosens Bioelectron. 2013;52C:255-260Two different fibrinogen (Fib) amperometric immunosensing designs based on the use of magnetic beads (MBs) and a novel specific nanobody (Nb) expressed in Escherichia coli are described for the first time. The immunological reaction for Fib detection was performed on COOH-MBs or His-Tag-Isolation-MBs as solid support for the immobilization of the antigen or the captured Nb. Direct and indirect competitive magnetoimmunosensing configurations have been tested and compared.

In the former one, Fib and biotinylated Fib competed for the immobilized Nb binding sites while the latter configuration involved competition of free Fib in solution and immobilized Fib for binding to a fixed amount of the specific biotinylated Nb. Labeling of the captured biotinylated Nb or antigen was made with streptavidin-HRP. The modified magnetic beads were captured by a neodymium magnet on the surface of screen-printed carbon electrodes (SPCEs). Amperometric detection was accomplished at −0.20 V (vs. Ag pseudo-reference electrode) by measuring the catalytic current arising upon addition of H2O2 and using hydroquinone (HQ) as redox mediator in solution. A better analytical performance was achieved with the indirect competitive immunoassay with a detection limit of 0.044 μg mL−1 Fib. The usefulness of both approaches was successfully demonstrated by analyzing an international standard for Fib plasma. The assays could be carried out in diluted plasma samples in a total analysis time of 90 min.

PNAS. 2013;110(39):15818-23

Barboza L, Effgen S, Alonso-Blanco C, Kooke R, Keurentjes JJ, Koornneef M, Alcázar R.

PNAS. 2013;110(39):15818-23Understanding the genetic bases of natural variation for developmental and stress-related traits is a major goal of current plant biology. Variation in plant hormone levels and signaling might underlie such phenotypic variation occurring even within the same species. Here we report the genetic and molecular basis of semidwarf individuals found in natural Arabidopsis thaliana populations.

Allelism tests demonstrate that independent loss-of-function mutations at GA locus 5 (GA5), which encodes gibberellin 20-oxidase 1 (GA20ox1) involved in the last steps of gibberellin biosynthesis, are found in different populations from southern, western, and northern Europe; central Asia; and Japan. Sequencing of GA5 identified 21 different loss-of-function alleles causing semidwarfness without any obvious general tradeoff affecting plant performance traits. GA5 shows signatures of purifying selection, whereas GA5 loss-of-function alleles can also exhibit patterns of positive selection in specific populations as shown by Fay and Wu’s H statistics.

These results suggest that antagonistic pleiotropy might underlie the occurrence of GA5 loss-of-function mutations in nature. Furthermore, because GA5 is the ortholog of rice SD1 and barley Sdw1/Denso green revolution genes, this study illustrates the occurrence of conserved adaptive evolution between wild A.thaliana and domesticated plants.

PLoS ONE 8(9): e75126

Salema V, Marín E, Martínez-Arteaga R, Ruano-Gallego D, Fraile S, Margolles Y, Teira X, Gutierrez C, Bodelón G, Fernández LA.

PLoS ONE 8(9): e75126Screening of antibody (Ab) libraries by direct display on the surface of E. coli cells is hampered by the presence of the outer membrane (OM). In this work we demonstrate that the native β-domains of EhaA autotransporter and intimin, two proteins from enterohemorrhagic E. coli O157:H7 (EHEC) with opposite topologies in the OM, are effective systems for the display of immune libraries of single domain Abs (sdAbs) from camelids (nanobodies or VHH) on the surface of E. coli K-12 cells and for the selection of high affinity sdAbs using magnetic cell sorting (MACS).

We analyzed the capacity of EhaA and intimin β-domains to display individual sdAbs and sdAb libraries obtained after immunization with the extracellular domain of the translocated intimin receptor from EHEC (TirMEHEC). We demonstrated that both systems displayed functional sdAbs on the surface of E. coli cells with little proteolysis and cellular toxicity, although E. coli cells displaying sdAbs with the β-domain of intimin showed higher antigen-binding capacity. Both E. coli display libraries were screened for TirMEHEC binding clones by MACS. High affinity binders were selected by both display systems, although more efficiently with the intimin β-domain. The specificity of the selected clones against TirMEHEC was demonstrated by flow cytometry of E. coli cells, along with ELISA and surface plasmon resonance with purified sdAbs. Finally, we employed the E. coli cell display systems to provide an estimation of the affinity of the selected sdAb by flow cytometry analysis under equilibrium conditions.

Cytoskeleton (Hoboken). 2013 Jul 2

Van Audenhove I, Van Impe K, Ruano-Gallego D, De Clercq S, De Muynck K, Vanloo B, Verstraete H, Fernández LA, Gettemans J.

Cytoskeleton (Hoboken). 2013 Jul 2Nanobodies or VHHs are single domain antigen binding fragments derived from heavy-chain antibodies naturally occurring in species of the Camelidae. Due to their ease of cloning, high solubility and intrinsic stability, they can be produced at low cost. Their small size, combined with high affinity and antigen specificity, enables recognition of a broad range of structural (undruggable) proteins and enzymes alike.

Focusing on two actin binding proteins, gelsolin and CapG, we summarize a general protocol for the generation, cloning and production of nanobodies. Furthermore, we describe multiple ways to characterize antigen-nanobody binding in more detail and we shed light on some applications with recombinant nanobodies. The use of nanobodies as intrabodies is clarified through several case studies revealing new cytoskeletal protein properties and testifying to the utility of nanobodies as intracellular bona fide protein inhibitors. Moreover, as nanobodies can traverse the plasma membrane of eukaryotic cells by means of the enteropathogenic E. coli type III protein secretion system, we show that in this promising way of nanobody delivery, actin pedestal formation can be affected following nanobody injection.

MBio. 2013 Sep 10;4(5). pii: e00650-13

Almazán F, Dediego ML, Sola I, Zuñiga S, Nieto-Torres JL, Marquez-Jurado S, Andrés G, Enjuanes L.

MBio. 2013 Sep 10;4(5). pii: e00650-13Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging coronavirus infecting humans that is associated with acute pneumonia, occasional renal failure, and a high mortality rate and is considered a threat to public health. The construction of a full-length infectious cDNA clone of the MERS-CoV genome in a bacterial artificial chromosome is reported here, providing a reverse genetics system to study the molecular biology of the virus and to develop attenuated viruses as vaccine candidates.

Following transfection with the cDNA clone, infectious virus was rescued in both Vero A66 and Huh-7 cells. Recombinant MERS-CoVs (rMERS-CoVs) lacking the accessory genes 3, 4a, 4b, and 5 were successfully rescued from cDNA clones with these genes deleted. The mutant viruses presented growth kinetics similar to those of the wild-type virus, indicating that accessory genes were not essential for MERS-CoV replication in cell cultures. In contrast, an engineered mutant virus lacking the structural E protein (rMERS-CoV-ΔE) was not successfully rescued, since viral infectivity was lost at early passages. Interestingly, the rMERS-CoV-ΔE genome replicated after cDNA clone was transfected into cells.

The infectious virus was rescued and propagated in cells expressing the E protein in trans, indicating that this virus was replication competent and propagation defective. Therefore, the rMERS-CoV-ΔE mutant virus is potentially a safe and promising vaccine candidate to prevent MERS-CoV infection.

Plant J. 2013 Mar;73(5):862-72

Ballesteros I, Domínguez T, Sauer M, Paredes P, Duprat A, Rojo E, Sanmartín M, Sánchez-Serrano JJ.

Plant J. 2013 Mar;73(5):862-72Protein phosphorylation is a key molecular switch used to transmit information in biological signalling networks. The output of these signalling circuits is governed by the counteracting activities of protein kinases and phosphatases that determine the direction of the switch. Whereas many kinases have been functionally characterized, it has been difficult to ascribe precise cellular roles to plant phosphatases, which are encoded by enlarged gene families that may provide a high degree of genetic redundancy.

In this work we have analysed the role in planta of catalytic subunits of protein phosphatase 2A (PP2A), a family encoded by five genes in Arabidopsis. Our results indicate that the two members of subfamily II, PP2A-C3 and PP2A-C4, have redundant functions in controlling embryo patterning and root development, processes that depend on auxin fluxes. Moreover, polarity of the auxin efflux carrier PIN1 and auxin distribution, determined with the DR5pro:GFP proxy, are affected by mutations in PP2A-C3 and PP2A-C4. Previous characterization of mutants in putative PP2A regulatory subunits had established a link between this class of phosphatases and PIN dephosphorylation and subcellular distribution. Building on those findings, the results presented here suggest that PP2A-C3 and PP2A-C4 catalyse this reaction and contribute critically to the establishment of auxin gradients for proper plant development.

PLoS Genet. 2013 Aug;9(8):e1003764

Pérez-Pantoja D, Nikel PI, Chavarría M, de Lorenzo V.

PLoS Genet. 2013 Aug;9(8):e1003764Environmental strain Burkholderia sp. DNT mineralizes the xenobiotic compound 2,4-dinitrotoluene (DNT) owing to the catabolic dnt genes borne by plasmid DNT, but the process fails to promote significant growth.

To investigate this lack of physiological return of such an otherwise complete metabolic route, cells were exposed to DNT under various growth conditions and the endogenous formation of reactive oxygen species (ROS) monitored in single bacteria. These tests revealed the buildup of a strong oxidative stress in the population exposed to DNT. By either curing the DNT plasmid or by overproducing the second activity of the biodegradation route (DntB) we could trace a large share of ROS production to the first reaction of the route, which is executed by the multicomponent dioxygenase encoded by the dntA gene cluster. Naphthalene, the ancestral substrate of the dioxygenase from which DntA has evolved, also caused significant ROS formation. That both the old and the new substrate brought about a considerable cellular stress was indicative of a still-evolving DntA enzyme which is neither optimal any longer for naphthalene nor entirely advantageous yet for growth of the host strain on DNT. We could associate endogenous production of ROS with likely error-prone repair mechanisms of DNA damage, and the ensuing stress-induced mutagenesis in cells exposed to DNT. It is thus plausible that the evolutionary roadmap for biodegradation of xenobiotic compounds like DNT was largely elicited by mutagenic oxidative stress caused by faulty reactions of precursor enzymes with novel but structurally related substrates-to-be.

Springerplus. 2013 Aug 21;2:392

Fernández-Nestosa MJ, Monturus E, Sánchez Z, Torres FS, Fernández AF, Fraga MF, Hernández P, Schvartzman JB, Krimer DB.

Springerplus. 2013 Aug 21;2:392In mice, the proviral integration of the Friend Spleen Focus Forming Virus (SFFV) within the PU.1 locus of erythroid precursors results in the development of erythroleukemia. SFFV integrates several kilobases upstream of the PU.1 transcription initiation start site leading to the constitutive activation of the gene which in turn results in a block of erythroid differentiation. In this study we have mapped and sequenced the exact location of the retroviral integration site. We have shown that SFFV integrates downstream of a previously described upstream regulatory element (URE), precisely 2,976 bp downstream of the URE-distal element. We have also found that SFFV persists integrated within the same location in resistant cell lines that have lost their differentiation capacity and in which case PU.1 remains silent. We have examined the methylation status of PU.1 and found that in resistant cells the nearby CpG islands remained methylated in contrast to a non-methylated status of the parental cell lines. Treatment with 5-aza-2'-deoxycytidine caused resistant cells to differentiate yet only when combined with HMBA. Altogether these results strongly suggest that methylation plays a crucial role with regard to PU.1 silencing. However, although demethylation is required, it is not sufficient to overcome the differentiation impasse. We have also showed that activation blockage of the Epo/Epo-R pathway remains despite of the absence of PU.1.

J Biol Chem. 2013 Jul 24

Cuervo A, Pulido-Cid M, Chagoyen M, Arranz R, González-García VA, Garcia-Doval C, Castón JR, Valpuesta JM, van Raaij MJ, Martín-Benito J, Carrascosa JL.

J Biol Chem. 2013 Jul 24Most bacterial viruses need a specialized machinery, called “tail,” to inject their genomes inside the bacterial cytoplasm without disrupting the cellular integrity. Bacteriophage T7 is a well characterized member of the Podoviridae family infecting Escherichia coli, and it has a short noncontractile tail that assembles sequentially on the viral head after DNA packaging. The T7 tail is a complex of around 2.7 MDa composed of at least four proteins as follows: the connector (gene product 8, gp8), the tail tubular proteins gp11 and gp12, and the fibers (gp17).

Using cryo-electron microscopy and single particle image reconstruction techniques, we have determined the precise topology of the tail proteins by comparing the structure of the T7 tail extracted from viruses and a complex formed by recombinant gp8, gp11, and gp12 proteins. Furthermore, the order of assembly of the structural components within the complex was deduced from interaction assays with cloned and purified tail proteins. The existence of common folds among similar tail proteins allowed us to obtain pseudo-atomic threaded models of gp8 (connector) and gp11 (gatekeeper) proteins, which were docked into the corresponding cryo-EM volumes of the tail complex. This pseudo-atomic model of the connector-gatekeeper interaction revealed the existence of a common molecular architecture among viruses belonging to the three tailed bacteriophage families, strongly suggesting that a common molecular mechanism has been favored during evolution to coordinate the transition between DNA packaging and tail assembly.

J Control Release. 2013 Jul 29;171(2):225-233

Mejías R, Gutiérrez L, Salas G, Pérez-Yagüe S, Zotes TM, Lázaro FJ, Morales MP, Barber DF.

J Control Release. 2013 Jul 29;171(2):225-233Although iron oxide magnetic nanoparticles (MNP) have been proposed for numerous biomedical applications, little is known about their biotransformation and long-term toxicity in the body. Dimercaptosuccinic acid (DMSA)-coated magnetic nanoparticles have been proven efficient for in vivo drug delivery, but these results must nonetheless be sustained by comprehensive studies of long-term distribution, degradation and toxicity.

We studied DMSA-coated magnetic nanoparticle effects in vitro on NCTC 1469 non-parenchymal hepatocytes, and analyzed their biodistribution and biotransformation in vivo in C57BL/6 mice. Our results indicate that DMSA-coated magnetic nanoparticles have little effect on cell viability, oxidative stress, cell cycle or apoptosis on NCTC 1469 cells in vitro. In vivo distribution and transformation were studied by alternating current magnetic susceptibility measurements, a technique that permits distinction of MNP from other iron species. Our results show that DMSA-coated MNP accumulate in spleen, liver and lung tissues for extended periods of time, in which nanoparticles undergo a process of conversion from superparamagnetic iron oxide nanoparticles to other non-superparamagnetic iron forms, with no significant signs of toxicity. This work provides the first evidence of DMSA-coated magnetite nanoparticle biotransformation in vivo.

¡Atención! Este sitio usa cookies y tecnologías similares.

Si continua navegando o no cambia su configuración, consideramos que acepta su uso. Saber más

Acepto

POLÍTICA DE COOKIES

Una cookie es un archivo de texto que se almacena en el ordenador o dispositivo móvil mediante un servidor Web y tan solo ese servidor será capaz de recuperar o leer el contenido de la cookie y permiten al Sitio Web recordar preferencias de navegación y navegar de manera eficiente. Las cookies hacen la interacción entre el usuario y el sitio Web más rápida y fácil.

Información general

Está página Web utiliza cookies. Las cookies son pequeños archivos de texto generados por las páginas web que usted visita, las cuales contienen los datos de sesión que pueden ser de utilidad posteriormente en la página web. De esta forma esta Web recuerda información sobre su visita, lo que puede facilitar su próxima visita y hacer que el sitio Web le resulte más útil.

¿Cómo funcionan las cookies?

Las cookies sólo pueden almacenar texto, por lo general siempre es anónimo y cifrado. No se almacenarán información personal alguna en una cookie, ni pueden asociarse a persona identificada o identificable.

Los datos permiten que esta Web pueda mantener su información entre las páginas, y también para analizar la forma de interactuar con el sitio Web. Las cookies son seguras ya que sólo pueden almacenar la información que se puso en su lugar por el navegador, lo que es información que el usuario ha introducido en el navegador o la que se incluye en la solicitud de página. No puede ejecutar el código y no se puede utilizar para acceder a su ordenador. Si una página web cifra la información de la cookie, sólo la página web puede leer la información.

¿Qué tipos de cookies utilizamos?

Las cookies que utiliza esta página Web se pueden distinguir según los siguientes criterios:

1. Tipos de cookies según la entidad que las gestiona:

Según quien sea la entidad que gestione el equipo o dominio desde donde se envían las cookies y trate los datos que se obtengan, podemos distinguir:

- Cookies propias: son aquellas que se envían al equipo terminal del usuario desde un equipo o dominio gestionado por el propio editor y desde el que se presta el servicio solicitado por el usuario.

- Cookies de terceros: son aquellas que se envían al equipo terminal del usuario desde un equipo o dominio que no es gestionado por el editor, sino por otra entidad que trata los datos obtenidos través de las cookies.

En el caso de que las cookies sean instaladas desde un equipo o dominio gestionado por el propio editor pero la información que se recoja mediante éstas sea gestionada por un tercero, no pueden ser consideradas como cookies propias.

2. Tipos de cookies según el plazo de tiempo que permanecen activadas:

Según el plazo de tiempo que permanecen activadas en el equipo terminal podemos distinguir:

- Cookies de sesión: son un tipo de cookies diseñadas para recabar y almacenar datos mientras el usuario accede a una página web. Se suelen emplear para almacenar información que solo interesa conservar para la prestación del servicio solicitado por el usuario en una sola ocasión (p.e. una lista de productos adquiridos).

- Cookies persistentes: son un tipo de cookies en el que los datos siguen almacenados en el terminal y pueden ser accedidos y tratados durante un periodo definido por el responsable de la cookie, y que puede ir de unos minutos a varios años.

3. Tipos de cookies según su finalidad:

Según la finalidad para la que se traten los datos obtenidos a través de las cookies, podemos distinguir entre:

- Cookies técnicas: son aquellas que permiten al usuario la navegación a través de una página web, plataforma o aplicación y la utilización de las diferentes opciones o servicios que en ella existan como, por ejemplo, controlar el tráfico y la comunicación de datos, identificar la sesión, acceder a partes de acceso restringido, recordar los elementos que integran un pedido, realizar el proceso de compra de un pedido, realizar la solicitud de inscripción o participación en un evento, utilizar elementos de seguridad durante la navegación, almacenar contenidos para la difusión de vídeos o sonido o compartir contenidos a través de redes sociales.

- Cookies de personalización: son aquellas que permiten al usuario acceder al servicio con algunas características de carácter general predefinidas en función de una serie de criterios en el terminal del usuario como por ejemplo serian el idioma, el tipo de navegador a través del cual accede al servicio, la configuración regional desde donde accede al servicio, etc.

- Cookies de análisis: son aquellas que permiten al responsable de las mismas, el seguimiento y análisis del comportamiento de los usuarios de los sitios web a los que están vinculadas. La información recogida mediante este tipo de cookies se utiliza en la medición de la actividad de los sitios web, aplicación o plataforma y para la elaboración de perfiles de navegación de los usuarios de dichos sitios, aplicaciones y plataformas, con el fin de introducir mejoras en función del análisis de los datos de uso que hacen los usuarios del servicio.

Herramienta de gestión de las cookies

Está página Web utiliza Google Analytics.

Google Analytics es una herramienta gratuita de análisis web de Google que principalmente permite que los propietarios de sitios web conozcan cómo interactúan los usuarios con su sitio web. Asimismo, habilita cookies en el dominio del sitio en el que te encuentras y utiliza un conjunto de cookies denominadas "__utma" y "__utmz" para recopilar información de forma anónima y elaborar informes de tendencias de sitios web sin identificar a usuarios individuales.

Para realizar las estadísticas de uso de esta Web utilizamos las cookies con la finalidad de conocer el nivel de recurrencia de nuestros visitantes y los contenidos que resultan más interesantes. De esta manera podemos concentrar nuestros esfuerzos en mejorar las áreas más visitadas y hacer que el usuario encuentre más fácilmente lo que busca. En esta Web puede utilizarse la información de su visita para realizar evaluaciones y cálculos estadísticos sobre datos anónimos, así como para garantizar la continuidad del servicio o para realizar mejoras en sus sitios Web. Para más detalles, consulte en el siguiente enlace la política de privacidad [http://www.google.com/intl/es/policies/privacy/]

Cómo gestionar las cookies en su equipo: la desactivación y eliminación de las cookies

Todos los navegadores de Internet le permiten limitar el comportamiento de una cookie o desactivar las cookies dentro de la configuración o las opciones del navegador. Los pasos para hacerlo son diferentes para cada navegador, se pueden encontrar instrucciones en el menú de ayuda de su navegador.

Si no acepta el uso de las cookies, ya que es posible gracias a los menús de preferencias o ajustes de su navegador, rechazarlas, este sitio Web seguirá funcionando adecuadamente sin el uso de las mismas.

Puede usted permitir, bloquear o eliminar las cookies instaladas en su equipo mediante la configuración de las opciones del navegador instalado en su ordenador:

- Para más información sobre Internet Explorer pulse aquí.
- Para más información sobre Chrome pulse aquí.
- Para más información sobre Safari pulse aquí.
- Para más información sobre Firefox pulse aquí.

A través de su navegador, usted también puede ver las cookies que están en su ordenador, y borrarlas según crea conveniente. Las cookies son archivos de texto, los puede abrir y leer el contenido. Los datos dentro de ellos casi siempre están cifrados con una clave numérica que corresponde a una sesión en Internet por lo que muchas veces no tienen sentido más allá que la página web que los escribió.

Consentimiento informado

La utilización de la presente página Web por su parte, implica que Vd. presta su consentimiento expreso e inequívoco a la utilización de cookies, en los términos y condiciones previstos en esta Política de Cookies, sin perjuicio de las medidas de desactivación y eliminación de las cookies que Vd. pueda adoptar, y que se mencionan en el apartado anterior.